Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Insights
  2. Events
  3. About
  4. Contact Us
MAIN/search
MAIN/Insights
Insights/
Our Latest Whitepapers

Get the latest insights on our life sciences, healthcare, and medical technology solutions in Asia Pacific. 

Learn More
Blogs, Case Studies & Podcasts

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

Discover Insights

IQVIA APAC Insight

"A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the Asia Pacific healthcare market.

Read The Latest Issue
MAIN/Events
Events/
Upcoming Events & Webinars

View our upcoming events and webinars.

Explore The Latest
On-Demand Webinars

Visit our library of on-demand webinars.

Discover Insights

Featured Event

"Unlocking the Future of Consumer Health: A Special Focus on Senior Consumers

Learn More
MAIN/About
About/
Newsroom

Read the latest updates and press releases.

Learn More
Career Opportunities

Improving human health requires innovative thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.

Search Jobs

APAC FOOTPRINT

"Explore our Asia Pacific locations.

Learn more
MAIN/Contact Us
Contact Us/
Webinar
Maximize your early phase oncology assets with a successful drug development plan.
calendar

July 27, 2022

Calendar
clock

10:00am - 11:15am

(GMT+08:00)

Register

  • Locations
  • Asia Pacific
  • Maximize your early phase oncology assets with a successful drug development plan.
View all IQVIA events
View now

The drug development landscape in Asia Pacific is accelerating more than ever before. Emerging biotech companies now face multiple hurdles in the clinical development process – from learning to prioritize the right target indication, effectively designing robust clinical study program with integration of right biomarkers ultimately seeking compressed development timelines.

With increasing trial complexity and decreasing success rate for oncology assets in the clinical productivity index, it is critical for small sponsors to identify the right target disease indication and consider the appropriate biomarker strategies right from the start of your early clinical development plan.

Why you should attend:
  • Learn how Indication Prioritization analysis can increase the return of investment of your oncology assets
  • Gain insights into how IQVIA Biotech can support your oncology early assets through our CDP oncology program
  • Learn how to integrate biomarker strategies in the framework of clinical trial and laboratory operations

Join this webinar to learn how JAPAC IQVIA Biotech leverages data and expertise to support your strategic drug development for early oncology assets to ensure your success.



Key speakers

Christopher Hart
Senior Director, Drug Development Lead, Planning and Design Operations

Eric Groves
Vice President, Strategic Drug Development, Design and Delivery Innovation

Bradley Smith
Vice President, Strategic Drug Development, Translational Medicine

Megan McCausland
Scientific Advisor, Q2 Solutions

Contact Us